Pain Relief
Consistent use reduces both acute and chronic pain by increasing cellular energy, reducing nerve compression inflammation, and interrupting pain signal transmission through gate control mechanisms.
The Science
Learn how photobiomodulation works at the cellular level, and why ALIO's dual wavelength technology delivers results that single therapy devices simply cannot match.
01 / The Process
A simple breakdown of the process through which red and near infrared light helps your body recover and repair from the inside out.
Your cells contain mitochondria, tiny structures that generate the energy your body uses for every function. When red and near infrared light penetrates the skin, the mitochondria absorb it directly, much like plants absorbing sunlight.
Light absorption triggers a significant increase in Adenosine Triphosphate (ATP) production, the primary energy molecule in every human cell. More ATP means more fuel for repair, regeneration, and recovery.
With higher energy availability, cells perform their specialized roles more efficiently. They repair damaged tissue faster, replicate more reliably, and resist oxidative stress more effectively.
This cascade triggers downstream benefits throughout the body: reduced inflammation, increased collagen synthesis, improved local circulation, and accelerated healing of soft tissue and nerve compression.
ALIO devices emit both 660nm (red) and 850nm (near infrared) wavelengths simultaneously. Red light targets surface tissue. Near infrared penetrates 4 to 5mm deeper, reaching tendons, ligaments, compressed nerves, and intervertebral discs, the structures most affected by occupational and repetitive strain.
02 / Benefits
The effects of photobiomodulation go beyond pain relief. They impact recovery speed, tissue health, and long term physical resilience.
Consistent use reduces both acute and chronic pain by increasing cellular energy, reducing nerve compression inflammation, and interrupting pain signal transmission through gate control mechanisms.
Photobiomodulation suppresses pro inflammatory cytokines and reduces oxidative stress at the cellular level, addressing the root driver of most musculoskeletal pain conditions.
By stimulating mitochondrial activity and improving local blood flow, ALIO devices accelerate the body's natural repair cycle after physical demand, injury, or repetitive microtrauma.
Near infrared wavelengths (850nm) penetrate deep enough to reach compressed nerve structures, including the median nerve in carpal tunnel syndrome and the sciatic nerve in lumbar disc conditions.
03 / Technology
Engineered for the human body. Not for the spec sheet.
All ALIO devices emit a precisely calibrated combination of 660nm red light and 850nm near infrared light simultaneously. This dual output is not accidental. It reflects the two most studied wavelengths in published photobiomodulation research, selected for their complementary depth of penetration and tissue specific mechanism of action.
Red Light
660nm
Targets skin, surface tissue, and superficial inflammatory response. Best studied for wound healing, collagen stimulation, and localized pain relief.
Near Infrared
850nm
Reaches muscle, tendon, ligament, and nerve tissue. The primary wavelength studied for deep pain relief, nerve regeneration, and joint inflammation.
Together, they address both surface and deep tissue simultaneously, in a single 15 to 20 minute session.
04 / Research
ALIO devices are built on the same wavelength science studied in these published clinical trials.
Lasers in Medical Science · 2024
A 2024 systematic review and meta analysis confirmed that photobiomodulation, including LED based devices at 660nm and 850nm, produced clinically meaningful improvements in pain, grip strength, and nerve conduction velocity in carpal tunnel syndrome patients.
PubMed ID: 39776290Photobiomodulation, Photomedicine & Laser Surgery · 2023
A 2023 randomized controlled trial found that photobiomodulation therapy accelerated nerve recovery, reduced post procedural pain, and improved hand function outcomes compared to control groups.
PubMed ID: 37506348Lasers in Medical Science · 2023
A 2023 randomized, double blind, placebo controlled trial demonstrated significant reductions in chronic low back pain intensity and disability scores following photobiomodulation treatment compared to sham.
PubMed ID: 37814265These studies were conducted independently by third party researchers. ALIO did not conduct or fund these trials. Citations are provided for informational purposes only. Individual results may vary. ALIO devices are not intended to diagnose, treat, cure, or prevent any disease.
05 / Knowledge Base
March 12, 2025
The science behind red light therapy explained without jargon, what it does, what it does not do, and what the clinical evidence actually shows.
Read articleJanuary 28, 2025
A review of the published clinical literature on photobiomodulation for median nerve compression, including dosage, wavelength, and session frequency findings.
Read articleNovember 5, 2024
How red and near infrared light targets the mechanical and inflammatory drivers of lumbar pain, and what daily use looks like in practice.
Read article